Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2041 AL 2055

Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson's Disease Affected by COVID-19: A Narrative Review

Suri JS, Maindarkar MA, Paul S, Ahluwalia P, Bhagawati M, Saba L, Faa G, Saxena S, Singh IM, Chadha PS, Turk M, Johri A, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou AD, Misra DP, Agarwal V, Kitas GD, Kolluri R, Teji JS, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Sharma A, Rathore V, Fatemi M, Alizad A, Krishnan PR, Omerzu T, Naidu S, Nicolaides A, Paraskevas KI, Kalra M, Ruzsa Z, Fouda MM.

Diagnostics (Basel). 2022 Jun 24;12(7):1543. doi: 10.3390/diagnostics12071543.

Emerging Trends and Hotspots in Tai Chi Fall Prevention: Analysis and Visualization

Chen J, Xue X, Xu J, Zeng J, Xu F.

Int J Environ Res Public Health. 2022 Jul 7;19(14):8326. doi: 10.3390/ijerph19148326.

New Targets and New Technologies in the Treatment of Parkinson's Disease: A Narrative Review

Montemurro N, Aliaga N, Graff P, Escribano A, Lizana J.

Int J Environ Res Public Health. 2022 Jul 20;19(14):8799. doi: 10.3390/ijerph19148799.

Impact of Nutrition, Microbiota Transplant and Weight Loss Surgery on Dopaminergic Alterations in Parkinson's Disease and Obesity

Hamamah S, Hajnal A, Covasa M.

Int J Mol Sci. 2022 Jul 6;23(14):7503. doi: 10.3390/ijms23147503.

Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy

Tringali C, Giussani P.

Int J Mol Sci. 2022 Jul 15;23(14):7806. doi: 10.3390/ijms23147806.

The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System-A Systematic Review

Skowron K, Budzyńska A, Wiktorczyk-Kapischke N, Chomacka K, Grudlewska-Buda K, Wilk M, Wałecka-Zacharska E, Andrzejewska M, Gospodarek-Komkowska E.

Int J Mol Sci. 2022 Jul 15;23(14):7820. doi: 10.3390/ijms23147820.

Effectiveness of Therapies Based on Mirror Neuron System to Treat Gait in Patients with Parkinson's Disease-A Systematic Review

Lahuerta-Martín S, Llamas-Ramos R, Llamas-Ramos I.

J Clin Med. 2022 Jul 21;11(14):4236. doi: 10.3390/jcm11144236.

Oral Dysbiosis and Neurodegenerative Diseases: Correlations and Potential Causations

Nicholson JS, Landry KS.

Microorganisms. 2022 Jun 30;10(7):1326. doi: 10.3390/microorganisms10071326.

Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging-A Review

Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C.

Microorganisms. 2022 Jul 12;10(7):1405. doi: 10.3390/microorganisms10071405.

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside

Basile MS, Bramanti P, Mazzon E.

Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644.

Nutrition and Gut-Brain Pathways Impacting the Onset of Parkinson's Disease

Terenzi D, Muth AK, Park SQ.

Nutrients. 2022 Jul 6;14(14):2781. doi: 10.3390/nu14142781.

Gut Microbes and Neuropathology: Is There a Causal Nexus?

Dinan K, Dinan TG.

Pathogens. 2022 Jul 14;11(7):796. doi: 10.3390/pathogens11070796.

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement

Zhang H, Yao L, Zheng Z, Koc S, Lu G.

Pharmaceuticals (Basel). 2022 Jun 30;15(7):811. doi: 10.3390/ph15070811.

GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders

Martínez-Bailén M, Clemente F, Matassini C, Cardona F.

Pharmaceuticals (Basel). 2022 Jul 2;15(7):823. doi: 10.3390/ph15070823.

Chalcones as Potential Ligands for the Treatment of Parkinson's Disease

Królicka E, Kieć-Kononowicz K, Łażewska D.

Pharmaceuticals (Basel). 2022 Jul 10;15(7):847. doi: 10.3390/ph15070847.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias